Innovative Focus GERO operates at the forefront of AI-driven drug discovery targeting age-related diseases, presenting opportunities to collaborate with biopharmaceutical companies seeking cutting-edge solutions for aging populations.
Growing Market Presence With a focus on preclinical research and leveraging AI technology, GERO is well-positioned to partner with biotech firms and research organizations aiming to accelerate drug development pipelines.
Research & Publications GERO’s existing publications and active knowledge base indicate a strong emphasis on scientific credibility, which can facilitate partnership discussions with academic institutions and government grants.
Tech Stack Compatibility Utilizing modern web and data analytics tools like Google Analytics and Webflow suggests openness to technical integrations and collaborations with companies interested in data insights and digital platform development.
Funding & Growth With substantial funding and a revenue range of up to 1B, GERO has the financial capacity to pursue strategic partnerships, joint ventures, or licensing deals with firms looking to expand their portfolio in aging and disease research.
$10M$25M
$10M$25M
$250M$500M
$1B$10B
$10M$25MGERO uses 8 technology products and services including Tilda, Open Graph, Google Fonts API, and more. Explore GERO's tech stack below.
| GERO Email Formats | Percentage |
| First.Last@gero.ai | 43% |
| FL@gero.ai | 7% |
| First.Last@gero.ai | 43% |
| FL@gero.ai | 7% |
Biotechnology ResearchCalifornia, United States51-200 Employees
We are a preclinical stage AI drug discovery company with a mission to eliminate age-related diseases We use AI to build clinically relevant disease phenotypes in real-world human data and identify diseases with shared biology. Then WES-enabled genetic study on these phenotypes allows us to discover novel targets applicable to several indications at once. You can find our publications here: https://gero.ai/publications
Company Overview
Media & News
Funding & FinancialsGERO has raised a total of $4.5M of funding over 5 rounds. Their latest funding round was raised on Jan 08, 2024 in the amount of $4.5M.
GERO's revenue is estimated to be in the range of $500M$1B
Funding & FinancialsGERO has raised a total of $4.5M of funding over 5 rounds. Their latest funding round was raised on Jan 08, 2024 in the amount of $4.5M.
GERO's revenue is estimated to be in the range of $500M$1B
1-888-653-2347 
support@leadiq.com